Results 1 to 10 of about 11,680 (225)
Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity. [PDF]
BackgroundThere are unpredictable inter-individual differences in sensitivity to psoralen-UVA (PUVA) photochemotherapy, used to treat skin diseases including psoriasis. Psoralens are metabolised by cytochrome P450 enzymes (P450), and we hypothesised that
Yusuf Y Deeni +4 more
doaj +6 more sources
A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy [PDF]
Narrowband UVB (NB-UVB) phototherapy and psoralen-UVA (PUVA) photochemotherapy are widely used phototherapeutic modalities for a range of skin diseases.
Sally H. Ibbotson
doaj +5 more sources
Management of mycosis fungoides and Sézary syndrome with mogamulizumab in combination with psoralen plus UVA: two case reports [PDF]
This report describes the cases of two patients with mycosis fungoides and Sézary syndrome (MF/SS) who achieved clinical benefit with mogamulizumab combination therapies.
Andrea Bernardelli, Carlo Visco
doaj +2 more sources
Inactivated whole-cell vaccines present a full repertoire of antigens to the immune system. Formalin treatment, a standard method for microbial inactivation, can modify or destroy protein antigenic epitopes.
Marlena M. Westcott +6 more
doaj +1 more source
Considering its effects, side effects, and contraindications, phototherapy is a treatment option that can be used in patients who do not respond to topical treatments, suffer side effects, or have diffuse lesions.
Melih Akyol
doaj +1 more source
Psoriasis is a chronic inflammatory proliferative skin disease involving various types of chemokines regulating immune cell migration, localization, and activation. Bath psoralen plus UVA (PUVA) treatment is an established phototherapy for psoriasis, but
Yoshifumi Kanayama +3 more
doaj +1 more source
Phototherapy combined with systemic agents for mycosis fungoides [PDF]
The choice of tactics for managing a patient with mycosis fungoides is determined by the stage of the disease. In the early stages of mycosis fungoides, a treatment approach using external therapy and various ultraviolet irradiation spectra (UVB-311 nm ...
Anastasiia A. Vorontsova +1 more
doaj +1 more source
Background: Psoriasis is a chronic, inflammatory, immune-mediated, debilitating skin disease affecting approximately 2%–3% of the global population.
Saikat Banerjee +3 more
doaj +1 more source
Subungual Squamous Cell Carcinoma in a Patient with Psoriasis
Subungual squamous cell carcinoma (SCC) is a rare malignant tumour with an indolent course and unknown aetiology. It is usually misdiagnosed as a benign lesion, resulting in delayed treatment.
Sherif Monib, Kevin Seebah
doaj +1 more source

